Form 8-K - Current report:
SEC Accession No. 0001789769-21-000050
Filing Date
2021-08-12
Accepted
2021-08-12 16:00:38
Documents
3
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q2-21instilbiox8xk.htm 8-K 31637
2 EX-99.1 q2-21earningspressrelease.htm EX-99.1 49501
3 LOGO image.jpg GRAPHIC 3565
  Complete submission text file 0001789769-21-000050.txt   87289
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 211167359
SIC: 2836 Biological Products, (No Diagnostic Substances)